Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00462618 · ClinicalTrials.gov registry record · Phase 2
Group Cognitive Behavioral Therapy (CBT I) Vs. Quetiapine for Residual Insomnia Impairing Recovery Among Elderly With Stable Major Affective Disorders
A Phase 2 study, sponsored by Michael E. DeBakey VA Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 32
- Enrollment target
NCT00462618 is a Phase 2 study that has completed, run by Michael E. DeBakey VA Medical Center. The registered enrollment target is 32 participants.
The verdict
NCT00462618, a Phase 2 study, has completed, sponsored by Michael E. DeBakey VA Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to assess feasibility and patient accessibility in order to design an adequately powered study to compare group cognitive behavioral therapy for insomnia (CBT-I) to quetiapine in non-demented patients aged 60 years or older with controlled bipolar disorder (I or II) or major depressive disorder who suffer from residual insomnia.
Interventions
- DRUG Quetiapine
- BEHAVIORAL Cogntive behavioral therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2007-04 |
| Est. Completion | 2008-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00462618
The ClinicalTrials.gov registry entry for NCT00462618 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michael E. DeBakey VA Medical Center, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Quetiapine is the first listed.
NCT00462618 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00462618 about?
NCT00462618 is a clinical study titled "Group Cognitive Behavioral Therapy (CBT I) Vs. Quetiapine for Residual Insomnia Impairing Recovery Among Elderly With Stable Major Affective Disorders". The purpose of this pilot study is to assess feasibility and patient accessibility in order to design an adequately powered study to compare group cognitive behavioral therapy for insomnia (CBT-I) to quetiapine in non-demented patients aged 60 years or older with controlled bipolar disorder (I or II...
What is the current status of trial NCT00462618?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2007-04. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00462618?
The interventions under investigation include: Quetiapine (DRUG), Cogntive behavioral therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00462618?
This trial is sponsored by Michael E. DeBakey VA Medical Center, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.